AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,509 | -2.1% | 1,935 | 0.0% | 0.00% | – |
| Q2 2023 | $4,605 | +29.4% | 1,935 | 0.0% | 0.00% | – |
| Q1 2023 | $3,560 | -3.2% | 1,935 | 0.0% | 0.00% | – |
| Q4 2022 | $3,677 | +267.7% | 1,935 | +993.2% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 177 | -55.0% | 0.00% | – |
| Q1 2022 | $2,000 | -75.0% | 393 | -75.5% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | -69.2% | 1,602 | -59.1% | 0.00% | -85.7% |
| Q3 2021 | $26,000 | -50.0% | 3,916 | -50.3% | 0.01% | -41.7% |
| Q2 2021 | $52,000 | +205.9% | 7,882 | +162.7% | 0.01% | +200.0% |
| Q1 2021 | $17,000 | +240.0% | 3,000 | +394.2% | 0.00% | +300.0% |
| Q4 2020 | $5,000 | -16.7% | 607 | +22.6% | 0.00% | -50.0% |
| Q3 2020 | $6,000 | -25.0% | 495 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | +100.0% | 495 | -19.6% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | – | 616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |